Charles Magro V
Charles Magro V's purchase track record
Charles Magro V has only 2 open-market purchases with a full 6 months of price history after it -- too few to call a track record yet.
| Purchase | Stock | Amount | 3 months | 6 months | S&P 500, 6 mo. |
|---|---|---|---|---|---|
| 2/6/2023 | CTVA | $2.43M | -4.9% | -9.6% | +9.9% |
| 2/11/2022 | CTVA | $2.56M | +9.2% | +21.9% | -3.1% |
Computed by MarketWall from SEC Form 4 filings and daily closing prices (close on the purchase date to the close about 3 and 6 months later). Companies that have since delisted are not included. Past results, not investment advice.
Associated companies
Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 17, 2026
Corteva Faces Post-Spin-Off Challenges as FMC Stock Crashes. Corteva faces a challenging environment post-Vylor spin-off, with analysts noting both upside and downside potential. In peer news, FMC Corp's stock plunged by more than 30% following a massive earnings downgrade and weak guidance. Market watchers anticipate a modest negative reaction for Corteva amid this sector-wide pressure.
Transaction History
| INGR | ▲ Buy | Grant | 1,797 | $193K | 5/20/2026 | View on chart |
| INGR | ▲ Buy | Grant | 380 | $43K | 3/31/2026 | View on chart |
| CTVA | ▼ Sell | Tax Withholding | 4,958 | $397K | 2/28/2026 | View on chart |
| CTVA | ▲ Buy | Grant | 108,376 | $0 | 2/24/2026 | View on chart |
| CTVA | ▼ Sell | Tax Withholding | 6,026 | $460K | 2/20/2026 | View on chart |
| CTVA | ▼ Sell | Tax Withholding | 5,319 | $407K | 2/18/2026 | View on chart |
| CTVA | ▲ Buy | Grant | 58,522 | $0 | 1/27/2026 | View on chart |
| CTVA | ▼ Sell | Tax Withholding | 23,562 | $1.7M | 1/27/2026 | View on chart |
| INGR | ▲ Buy | Grant | 615 | $66K | 12/5/2025 | View on chart |
| INGR | ▲ Buy | Grant | 532 | $66K | 9/30/2025 | View on chart |
| INGR | ▲ Buy | Grant | 482 | $66K | 6/30/2025 | View on chart |
| INGR | ▲ Buy | Grant | 499 | $66K | 3/31/2025 | View on chart |
| CTVA | ▼ Sell | Tax Withholding | 4,907 | $309K | 2/28/2025 | View on chart |
| CTVA | ▼ Sell | Tax Withholding | 5,964 | $381K | 2/20/2025 | View on chart |
| CTVA | ▼ Sell | Open Market | 46,905 | $3.0M | 2/19/2025 | View on chart |
| CTVA | ▲ Buy | Grant | 36,147 | $0 | 2/18/2025 | View on chart |
| CTVA | ▼ Sell | Tax Withholding | 5,347 | $345K | 2/18/2025 | View on chart |
| CTVA | ▼ Sell | Tax Withholding | 40,044 | $2.6M | 1/24/2025 | View on chart |
| CTVA | ▲ Buy | Grant | 96,920 | $0 | 1/24/2025 | View on chart |
| INGR | ▲ Buy | Grant | 455 | $66K | 12/12/2024 | View on chart |
| INGR | ▲ Buy | Grant | 489 | $66K | 9/30/2024 | View on chart |
| INGR | ▲ Buy | Grant | 574 | $66K | 6/28/2024 | View on chart |
| INGR | ▲ Buy | Grant | 567 | $66K | 3/29/2024 | View on chart |
| CTVA | ▼ Sell | Tax Withholding | 3,926 | $214K | 2/28/2024 | View on chart |
| CTVA | ▲ Buy | Grant | 40,471 | $0 | 2/20/2024 | View on chart |
| CTVA | ▼ Sell | Tax Withholding | 3,478 | $191K | 2/18/2024 | View on chart |
| INGR | ▲ Buy | Grant | 601 | $62K | 12/11/2023 | View on chart |
| INGR | ▲ Buy | Grant | 628 | $62K | 9/29/2023 | View on chart |
| INGR | ▲ Buy | Grant | 590 | $63K | 6/30/2023 | View on chart |
| INGR | ▲ Buy | Grant | 635 | $63K | 3/31/2023 | View on chart |
| CTVA | ▲ Buy | Grant | 32,911 | $0 | 2/28/2023 | View on chart |
| CTVA | ▼ Sell | Tax Withholding | 3,429 | $213K | 2/18/2023 | View on chart |
| CTVA | ▲ Buy | Open Market | 40,000 | $2.4M | 2/6/2023 | View on chart |
| INGR | ▲ Buy | Grant | 751 | $61K | 10/3/2022 | View on chart |
| INGR | ▲ Buy | Grant | 704 | $63K | 7/1/2022 | View on chart |
| INGR | ▲ Buy | Grant | 474 | $41K | 5/2/2022 | View on chart |
| CTVA | ▲ Buy | Grant | 35,503 | $1.8M | 2/18/2022 | View on chart |
| CTVA | ▲ Buy | Open Market | 3,750 | $193K | 2/11/2022 | View on chart |
| CTVA | ▲ Buy | Open Market | 46,250 | $2.4M | 2/11/2022 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 8, 2026
Ingredion Sees Rising Clean-Label Demand, UBS Lowers Target
Demand for clean‑label ingredients is growing, which has helped lift Ingredion’s share price. UBS kept a neutral stance but cut its price target to $104, citing uncertainty about future momentum. The company’s T&HS solutions are being examined for their ability to sustain growth into 2026.
Ingredion Sees Rising Clean-Label Demand, UBS Lowers Target. Demand for clean‑label ingredients is growing, which has helped lift Ingredion’s share price. UBS kept a neutral stance but cut its price target to $104, citing uncertainty about future momentum. The company’s T&HS solutions are being examined for their ability to sustain growth into 2026.